Sirona Pharma SRL
Sirona Pharma reported total assets of 138,027 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Apr 2026).
The score of Sirona Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets +104 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sirona Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Apr 2026
- Year ended 31 Dec 2024filed on 07 May 2025
- Year ended 31 Dec 2023filed on 02 Aug 2024
- Year ended 31 Dec 2022filed on 22 May 2023
- Year ended 31 Dec 2021filed on 28 Mar 2022
Sirona Pharma's financial analysis
- Solvency7.3%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sirona Pharma
Sirona Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.777.019
- VAT number
- BE0762777019
- Peppol
- Registered · 0208:0762777019 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Feb 2021
- Registered office
- 1040 Etterbeek
- Latest accounts
- 2025 · filed on 01 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sirona Pharma (SRL) has been based in Etterbeek since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 19,208 € and equity of 10,143 €; its revenue is not published. Its solvency stands at 7.3%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sirona Pharma
Companies in the same business, of comparable size and area, outside its group.
- Mont Royal Retail sale of pharmaceutical products Brussels · balance sheet 126,135 €
- Clement Pharma Services Retail sale of pharmaceutical products Meise · balance sheet 151,301 €
- Pharmacie de Bousval Retail sale of pharmaceutical products Genappe · balance sheet 139,616 €
- Apotheker Bosmans Kristien Retail sale of pharmaceutical products Merchtem · balance sheet 138,175 €
- Pharmacentre Retail sale of pharmaceutical products Wavre · balance sheet 138,900 €
- RiethPharma Retail sale of pharmaceutical products Mortsel · balance sheet 138,933 €
- C.V.Pharma Retail sale of pharmaceutical products Les Bons Villers · balance sheet 137,101 €
- Commuphar Retail sale of pharmaceutical products Antwerp · balance sheet 136,781 €
Frequently asked questions about Sirona Pharma
What is the revenue of Sirona Pharma?
Sirona Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sirona Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0762777019 for Sirona Pharma, if the company is VAT-registered. Its company number (CBE) is 0762.777.019.
Where is the registered office of Sirona Pharma?
According to the CBE register, the registered office of Sirona Pharma is in 1040 Etterbeek.
What is the equity of Sirona Pharma?
At the close of the 2025 financial year, the equity of Sirona Pharma amounts to 10,143 €, a solvency of 7.3% of total assets.
Who manages Sirona Pharma?
The register lists 2 active mandates at Sirona Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sirona Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →